Dr. Verma on Palbociclib Plus Fulvestrant for HR+/HER2- Breast Cancer

Article

Sunil Verma, MD, MSEd, FRCPC, discusses the PALOMA-3 trial, which examined palbociclib with or without fulvestrant for the treatment of patients with HR-positive, HER2-negative breast cancer.

Sunil Verma, MD, MSEd, FRCPC, medical director, Louise Temerty Breast Cancer Centre at Sunnybrook Health Sciences Centre, discusses the PALOMA-3 trial, which examined palbociclib with or without fulvestrant for the treatment of patients with HR-positive, HER2-negative breast cancer.

Recent Videos
Meaghan Mooney, B.S.N., RN, OCN, during the Extraordinary Healer interview
Colleen O’Leary, DNP, RN, AOCNS, EBP-C, LSSYB, in an interview with Oncology Nursing News.
Michelle H. Johann, DNP, RN, PHN, CPAN, WTA, in an interview with Oncology Nursing News explaining surgical path cards
Related Content
breast

T-DXd Demonstrated Intracranial Activity in HER2+ Breast Cancer

Kristi Rosa
September 13th 2024
Article

DESTINY-Breast12 results showed that T-DXd led to overall and intracranial activity in patients with HER2-positive metastatic breast cancer.

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Improving The Rate Of Accurate Inflammatory Breast Cancer Diagnoses

Lindsay Fischer
October 2nd 2023
Podcast

Ryan Tamargo, NP, AONCP, discusses the launch of an online inflammatory breast cancer scoring system tool.

Illustration of breast.

Gene Assay May Predict Responses to Extended Letrozole in Low-Risk Breast Cancer Subsets

Roman Fabbricatore
August 30th 2024
Article

A gene assay was predictive of response to extended letrozole therapy, identifying a subset of patients with low-risk breast cancer with improved outcomes.

The Vitals

Nurse Practitioners Weigh in on Data From the San Antonio Breast Cancer Symposium

Lindsay Fischer
January 16th 2023
Podcast

Loyda Braithwaite, MSN, RN, AGPCNP-BC, AOCNP; and Jamie Carroll, APRN, CNP, MSN, highlight presentations from the 2022 San Antonio Breast Cancer Symposium that will influence oncology nursing practice.

A nurse helping a woman during a mammogram

Nurse-led High Risk Referral Protocol Improves Risk Communications During Mammography Appointments

Spencer Feldman
August 27th 2024
Article

Increased use of consultations, breast MRIs, genetic counseling, and other testing in high-risk patients were a direct result from nurse-led high risk referral protocols.

AI May Predict Chronic Pain Risk in Patients With Breast Cancer

AI May Predict Chronic Pain Risk in Patients With Breast Cancer

Roman Fabbricatore
August 26th 2024
Article

A learning approach integrating time series and static data may improve understanding of breast cancer outcomes.

© 2024 MJH Life Sciences

All rights reserved.